Metabolic abnormalities of CD4+ T cells have been implicated in the pathogenesis of autoimmune diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) [20–22]. The gene discussed is CD4; the disease is rheumatoid arthritis.